Published in Mol Cell Biol on December 17, 2007
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev (2008) 2.71
TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer. J Clin Invest (2009) 1.50
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol (2011) 1.46
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J (2009) 1.45
Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J Biol Chem (2008) 1.43
Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy. Clin Cancer Res (2012) 1.33
DDB2 decides cell fate following DNA damage. Proc Natl Acad Sci U S A (2009) 1.22
Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene (2012) 1.19
Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem (2011) 1.16
Insights from mouse models into human retinoblastoma. Cell Div (2008) 1.13
14-3-3Tau regulates ubiquitin-independent proteasomal degradation of p21, a novel mechanism of p21 downregulation in breast cancer. Mol Cell Biol (2010) 1.06
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. Carcinogenesis (2009) 1.03
Cables1 controls p21/Cip1 protein stability by antagonizing proteasome subunit alpha type 3. Oncogene (2014) 0.98
MDM4 (MDMX) and its Transcript Variants. Curr Genomics (2009) 0.94
Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition. Cell Death Differ (2014) 0.92
Increased protein stability of CDKN1C causes a gain-of-function phenotype in patients with IMAGe syndrome. PLoS One (2013) 0.91
UVB-induced cell death signaling is associated with G1-S progression and transcription inhibition in primary human fibroblasts. PLoS One (2013) 0.89
Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex. Oncogene (2013) 0.89
MDMX exerts its oncogenic activity via suppression of retinoblastoma protein. Oncogene (2015) 0.88
Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein. J Biol Chem (2012) 0.84
Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways. PLoS One (2014) 0.82
A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer. PLoS One (2015) 0.82
Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications. Cancer Biol Ther (2012) 0.81
Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome. Cell Death Dis (2015) 0.80
High levels of Hdmx promote cell growth in a subset of uveal melanomas. Am J Cancer Res (2012) 0.80
14-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53. J Biol Chem (2010) 0.79
Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation. Elife (2016) 0.79
The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a. Oncogene (2013) 0.78
TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene. Sci Rep (2016) 0.78
IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity. J Biol Chem (2013) 0.77
MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation. Oncoscience (2014) 0.76
Targeting RING domains of Mdm2-MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells. Cell Death Dis (2015) 0.76
Suppression of the mouse double minute 4 gene causes changes in cell cycle control in a human mesothelial cell line responsive to ultraviolet radiation exposure. Environ Mol Mutagen (2009) 0.76
A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity. PLoS One (2015) 0.75
The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumorigenesis. J Pathol (2016) 0.75
BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma. Oncotarget (2017) 0.75
The role of MDM2 and MDM4 in breast cancer development and prevention. J Mol Cell Biol (2017) 0.75
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol (1999) 9.92
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (1994) 8.22
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol (2001) 6.43
Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science (2001) 6.29
p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol (1999) 5.40
Inactivation of the p53 pathway in retinoblastoma. Nature (2006) 4.57
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet (2001) 4.23
MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J (1996) 4.13
Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol Cell (2003) 3.91
Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem (2003) 3.68
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron (2003) 3.62
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell (2000) 3.42
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol (2003) 3.29
Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol Cell Biol (2002) 3.10
Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J Biol Chem (2002) 2.68
Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J (2004) 2.59
Endoproteolytic activity of the proteasome. Science (2002) 2.56
Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell (2003) 2.54
MdmX protects p53 from Mdm2-mediated degradation. Mol Cell Biol (2000) 2.50
Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol (1997) 2.41
MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell (2005) 2.29
Cell-cycle inhibitors: three families united by a common cause. Gene (2000) 2.28
A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J (2001) 2.22
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J (2003) 2.13
MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Biol (1999) 2.00
Mdm2 association with p53 targets its ubiquitination. Oncogene (1998) 1.94
MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem (2004) 1.93
Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle (2005) 1.88
Mdmx as an essential regulator of p53 activity. Biochem Biophys Res Commun (2005) 1.85
Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res (1999) 1.83
Hdmx stabilizes Mdm2 and p53. J Biol Chem (2000) 1.81
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. EMBO J (2006) 1.67
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation. Mol Cell Biol (2005) 1.56
Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun (2001) 1.49
N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). Mol Cell (2004) 1.45
Mdmx and Mdm2: brothers in arms? Cell Cycle (2004) 1.44
GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene (2002) 1.43
Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection. Biochemistry (2005) 1.41
N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J (2006) 1.40
Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem Biophys Res Commun (1996) 1.40
SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J (2002) 1.39
A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity. J Biol Chem (1999) 1.37
Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis. Mol Cell (2004) 1.34
Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation. Mol Cell Biol (2007) 1.32
UV Induces p21 rapid turnover independently of ubiquitin and Skp2. J Biol Chem (2006) 1.30
MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem (2002) 1.20
The contribution of the RING finger domain of MDM2 to cell cycle progression. Oncogene (2000) 1.09
Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth. Oncogene (2004) 1.08
Cyclin a-CDK phosphorylation regulates MDM2 protein interactions. J Biol Chem (2001) 1.01
Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells. J Cell Biochem (2003) 0.97
Constitutive mdmx expression during cell growth, differentiation, and DNA damage. DNA Cell Biol (1999) 0.95
Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. Am J Respir Cell Mol Biol (2000) 0.91
The MDM2 RING finger is required for cell cycle-dependent regulation of its protein expression. FEBS Lett (2003) 0.89
Direct proteasome inhibition by clasto-lactacystin beta-lactone permits the detection of ubiquitinated p21(waf1) in ML-1 cells. Biochim Biophys Acta (1999) 0.86
Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol (2004) 4.08
Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem (2004) 4.05
Signaling to p53: ribosomal proteins find their way. Cancer Cell (2009) 3.84
Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron (2003) 3.62
Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol (2008) 2.45
Ceramides modulate programmed cell death in plants. Genes Dev (2003) 2.22
5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J Biol Chem (2007) 2.13
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J (2003) 2.13
Inhibition of c-Myc activity by ribosomal protein L11. EMBO J (2007) 1.78
Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem (2008) 1.77
A systematic review of the management of hangman's fractures. Eur Spine J (2005) 1.74
Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol (2006) 1.72
Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. J Biol Chem (2008) 1.65
Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism. J Biol Chem (2006) 1.62
Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol (2009) 1.51
p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK. Proc Natl Acad Sci U S A (2008) 1.47
Prescription pattern and its influencing factors in Chinese county hospitals: a retrospective cross-sectional study. PLoS One (2013) 1.46
A plasmodesmata-localized protein mediates crosstalk between cell-to-cell communication and innate immunity in Arabidopsis. Plant Cell (2011) 1.45
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J (2006) 1.40
SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J (2002) 1.39
Involvement of the DNA repair protein hHR23 in p53 degradation. Mol Cell Biol (2003) 1.38
A key role for ALD1 in activation of local and systemic defenses in Arabidopsis. Plant J (2004) 1.35
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc. Neoplasia (2006) 1.34
Vital signs: communication between health professionals and their patients about alcohol use--44 states and the District of Columbia, 2011. MMWR Morb Mortal Wkly Rep (2014) 1.32
UV Induces p21 rapid turnover independently of ubiquitin and Skp2. J Biol Chem (2006) 1.30
Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem (2006) 1.29
Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions. J Am Chem Soc (2011) 1.29
Regulation of p53--insights into a complex process. Crit Rev Biochem Mol Biol (2009) 1.28
Binge drinking - United States, 2011. MMWR Surveill Summ (2013) 1.28
p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex. J Biol Chem (2002) 1.27
Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J Biol Chem (2006) 1.26
p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep (2011) 1.25
Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens (2008) 1.25
Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. Mol Cell Biol (2005) 1.25
Divergent roles in Arabidopsis thaliana development and defense of two homologous genes, aberrant growth and death2 and AGD2-LIKE DEFENSE RESPONSE PROTEIN1, encoding novel aminotransferases. Plant Cell (2004) 1.25
Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds. Proc Natl Acad Sci U S A (2009) 1.25
Versatile multi-wavelength ultrafast fiber laser mode-locked by carbon nanotubes. Sci Rep (2013) 1.24
SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection. Neoplasia (2006) 1.24
Multilevel regression and poststratification for small-area estimation of population health outcomes: a case study of chronic obstructive pulmonary disease prevalence using the behavioral risk factor surveillance system. Am J Epidemiol (2014) 1.23
Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery. Angew Chem Int Ed Engl (2011) 1.21
Nucleotide excision repair driven by the dissociation of CAK from TFIIH. Mol Cell (2008) 1.21
Plasmodesmata: the battleground against intruders. Trends Plant Sci (2011) 1.20
MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem (2002) 1.20
Crosstalk between the circadian clock and innate immunity in Arabidopsis. PLoS Pathog (2013) 1.19
A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53. EMBO Mol Med (2012) 1.18
Salicylic acid regulates Plasmodesmata closure during innate immune responses in Arabidopsis. Plant Cell (2013) 1.17
Autoregulatory suppression of c-Myc by miR-185-3p. J Biol Chem (2011) 1.16
Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol Cell Biol (2011) 1.13
Modeling spatial accessibility to parks: a national study. Int J Health Geogr (2011) 1.12
Mdm2 facilitates the association of p53 with the proteasome. Proc Natl Acad Sci U S A (2010) 1.11
Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry (2004) 1.09
Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth. Cancer Biol Ther (2012) 1.09
BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett (2008) 1.08
Multiple roles of WIN3 in regulating disease resistance, cell death, and flowering time in Arabidopsis. Plant Physiol (2011) 1.07
Prevalence of Healthy Sleep Duration among Adults - United States, 2014. MMWR Morb Mortal Wkly Rep (2016) 1.07
Signaling pathways that regulate the enhanced disease resistance of Arabidopsis "defense, no death" mutants. Mol Plant Microbe Interact (2008) 1.04
SCF TrCP1 activates and ubiquitylates TAp63gamma. J Biol Chem (2007) 1.02
A key role for the Arabidopsis WIN3 protein in disease resistance triggered by Pseudomonas syringae that secrete AvrRpt2. Mol Plant Microbe Interact (2007) 1.02
Feedback regulation of c-Myc by ribosomal protein L11. Cell Cycle (2007) 1.02
Regulation of p53 in embryonic stem cells. Exp Cell Res (2010) 1.02
MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation. J Biol Chem (2004) 1.01
p300 regulates p63 transcriptional activity. J Biol Chem (2005) 1.01
Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop. Cell Cycle (2010) 1.00
A cell-penetrating helical polymer for siRNA delivery to mammalian cells. Mol Ther (2012) 1.00
Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer (2012) 1.00
Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression. J Biol Chem (2010) 0.99
Reliability of classification systems for intertrochanteric fractures of the proximal femur in experienced orthopaedic surgeons. Injury (2005) 0.98
Evaluation and quantitation of intact wax esters of human meibum by gas-liquid chromatography-ion trap mass spectrometry. Invest Ophthalmol Vis Sci (2012) 0.98
MiR-1246: a new link of the p53 family with cancer and Down syndrome. Cell Cycle (2012) 0.98
MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem (2010) 0.97
Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer (2006) 0.97
Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion. J Biol Chem (2012) 0.97
Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. Mol Cell Biol (2006) 0.96
Novel method for the rapid isolation of RPE cells specifically for RNA extraction and analysis. Exp Eye Res (2012) 0.96
Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents. Neoplasia (2013) 0.96
Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer. Int J Cancer (2013) 0.95
A role for SSRP1 in recombination-mediated DNA damage response. J Cell Biochem (2009) 0.95
Human SSRP1 has Spt16-dependent and -independent roles in gene transcription. J Biol Chem (2007) 0.95
p53 in stem cells. World J Biol Chem (2011) 0.95